UDP-glucuronosyltransferase 1A4 (UGT1A4) polymorphisms in a Jordanian population

被引:14
作者
Hakooz, Nancy [1 ,2 ]
Alzubiedi, Sameh [2 ]
Yousef, Al-Motassem [2 ]
Arafat, Tawfiq [3 ]
Dajani, Rana [4 ]
Ababneh, Nidaa [5 ]
Ismail, Said [5 ]
机构
[1] Zarqa Univ, Fac Pharm, Zarqa 13132, Jordan
[2] Univ Jordan, Fac Pharm, Amman 11942, Jordan
[3] Jordan Ctr Pharmaceut Res, Amman 11195, Jordan
[4] Hashemite Univ, Dept Biol, Zarqa 13115, Jordan
[5] Univ Jordan, Fac Med, Amman 11942, Jordan
关键词
Drug metabolism; UGT1A4; Jordanian population; Polymorphism; CYP1A2 GENETIC POLYMORPHISMS; HUMAN LIVER-MICROSOMES; JAPANESE POPULATION; LEBANESE POPULATION; GLUCURONIDATION; PHARMACOGENETICS; TAMOXIFEN; PREVALENCE; TACROLIMUS; HAPLOTYPES;
D O I
10.1007/s11033-012-1615-y
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Glucuronidation is one of the most important phase II metabolic pathways. It is catalyzed by a family of UDP-glucuronosyltransferase enzymes (UGTs). One of the subfamilies is UGT1A. Allele frequencies in UGT1A4 differ among ethnic groups. The aim of this study was to determine the allelic frequency of two most common defective alleles: UGT1A4*2 and UGT1A4*3 in a Jordanian population. A total of 216 healthy Jordanian Volunteers (165 males and 51 females) were included in this study. Genotyping for UGT1A4*1, UGT1A4*2 and UGT1A4*3 was done using a well established polymerase chain reaction-restriction fragment length polymorphism test. Among 216 random individuals studied for UGT1A4*2 mutation there were 26 individuals who were heterozygous, giving a prevalence of 12% and an allele frequency of 6.5%. Only one individual was homozygous for UGT1A4*2. The UGT1A4*3 mutation was detected as heterozygous in 9 of 216 individuals indicating a prevalence of 4.2% and allele frequency of 3.5%. Three individuals were homozygous for the UGT1A4*3 indicating a prevalence of 1.4%. The prevalence of UGT1A4*2 is similar to the Caucasians but different from other populations whilst the UGT1A4*3 prevalence in the Jordanian population is distinct from other populations. Our results provide useful information for the Jordanian population and for future genotyping of Arab populations in general.
引用
收藏
页码:7763 / 7768
页数:6
相关论文
共 50 条
  • [31] Strong Inhibition of UDP-Glucuronosyltransferase (UGT) 1A1 by Levothyroxine Indicates the Potential UGT-Inhibition Based Adverse Effect of Levothyroxine
    Zhao, Hua-Dong
    Bao, Guo-Qiang
    He, Xian-Li
    Wu, Tao
    Wang, Cheng-Guo
    Wang, Sheng-Zhi
    Zang, Li
    Lu, Jian-Guo
    Du, Xi-Lin
    LATIN AMERICAN JOURNAL OF PHARMACY, 2012, 31 (05): : 761 - 763
  • [32] Strong Inhibition Capability of Wogonin towards UDP-Glucuronosyltransferase (UGT) 1A1 and 1A3
    Shan, Li-Na
    Shi, Xian-Bao
    LATIN AMERICAN JOURNAL OF PHARMACY, 2013, 32 (05): : 741 - 744
  • [33] Interactions Between Human UDP-Glucuronosyltransferase (UGT) 2B7 and UGT1A Enzymes
    Fujiwara, Ryoichi
    Nakajima, Miki
    Oda, Shingo
    Yamanaka, Hiroyuki
    Ikushiro, Shin-Ichi
    Sakaki, Toshiyuki
    Yokoi, Tsuyoshi
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2010, 99 (01) : 442 - 454
  • [34] Functional characterization of human and cynomolgus monkey UDP-glucuronosyltransferase 1A1 enzymes
    Hanioka, Nobumitsu
    Tanabe, Natsuko
    Jinno, Hideto
    Tanaka-Kagawa, Toshiko
    Nagaoka, Kenjiro
    Naito, Shinsaku
    Koeda, Akiko
    Narimatsu, Shizuo
    LIFE SCIENCES, 2010, 87 (7-8) : 261 - 268
  • [35] Genetic variations and haplotypes of UDP-glucuronosyltransferase 1 A locus in a Korean population
    Yea, Sung Su
    Lee, Sang Seop
    Kim, Woo-Young
    Liu, Kwang-Hyeon
    Shon, Ji-Hong
    Cha, In-June
    Shin, Jae-Gook
    THERAPEUTIC DRUG MONITORING, 2008, 30 (01) : 23 - 34
  • [36] Drug candidate glabridin affects UDP-glucuronosyltransferase (UGT) 1A4-catalyzed Metabolism of Children Neurological Diseases' Drug Trifluoperazine
    Li, Shu-Fen
    LATIN AMERICAN JOURNAL OF PHARMACY, 2016, 35 (09): : 2105 - 2107
  • [37] In vitro inhibition of human UDP-glucuronosyltransferase (UGT) 1A1 by osimertinib, and prediction of in vivo drug-drug interactions
    Wang, Zhe
    Wang, Xiaoyu
    Wang, Zhen
    Jia, Yaqin
    Feng, Yuyi
    Jiang, Lili
    Xia, Yangliu
    Cao, Jun
    Liu, Yong
    TOXICOLOGY LETTERS, 2021, 348 : 10 - 17
  • [38] Quantitative Analysis of UDP-Glucuronosyltransferase (UGT) 1A and UGT2B Expression Levels in Human Livers
    Izukawa, Takeshi
    Nakajima, Miki
    Fujiwara, Ryoichi
    Yamanaka, Hiroyuki
    Fukami, Tatsuki
    Takamiya, Masataka
    Aoki, Yasuhiro
    Ikushiro, Shin-ichi
    Sakaki, Toshiyuki
    Yokoi, Tsuyoshi
    DRUG METABOLISM AND DISPOSITION, 2009, 37 (08) : 1759 - 1768
  • [39] Alteration of the Function of the UDP-Glucuronosyltransferase 1A Subfamily by Cytochrome P450 3A4: Different Susceptibility for UGT Isoforms and UGT1A1/7 Variants
    Ishii, Yuji
    Koba, Hiroki
    Kinoshita, Kousuke
    Oizaki, Toshiya
    Iwamoto, Yuki
    Takeda, Shuso
    Miyauchi, Yuu
    Nishimura, Yoshio
    Egoshi, Natsuki
    Taura, Futoshi
    Morimoto, Satoshi
    Ikushiro, Shin'ichi
    Nagata, Kiyoshi
    Yamazoe, Yasushi
    Mackenzie, Peter I.
    Yamada, Hideyuki
    DRUG METABOLISM AND DISPOSITION, 2014, 42 (02) : 229 - 238
  • [40] Edaravone Affects the Activity of Bone Cancer Treatment Relevant Enzyme UDP-Glucuronosyltransferase (UGT) 1A1
    Dong, Zhen-Ling
    Ma, Hou-Hai
    Ma, Hou-Sheng
    LATIN AMERICAN JOURNAL OF PHARMACY, 2017, 36 (09): : 1839 - 1842